Telix Pharmaceuticals Ltd ($TLX)
Smith Darren Charlton โ Group Chief Financial Officer
Shares
2,071
Price
$9.66
Total Value
$19,997.58
P&L
+22.0% (+$4,398.80)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Smith Darren Charlton |
|---|---|
| Title | Group Chief Financial Officer |
| Transaction Date | Sep 7, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Ordinary Shares |
| Direct/Indirect | Direct |
| Filing Date | Sep 14, 2026 |
| Shares Purchased | 2,071 |
| Price per Share | $9.66 |
| Total Value | $19,997.58 |
| Shares Owned After | 13,992 |
| Derivative | No |
| Accession Number | 0001628280-26-061944 |
| Document | View SEC Filing |